Becton, Dickinson and Company (BD) is an American medical technology company founded in 1897. With over 125 years of experience, BD is a global leader in healthcare technology, focusing on improving medical discovery, diagnostics, and care delivery. The company reported approximately $20.2 billion in revenue for fiscal year 2024, showcasing its significant presence in the industry. BD offers a diverse range of products across various healthcare segments. This includes blood collection and diagnostics, where it introduced the BD Vacutainer® and automated blood culture systems. The company also pioneered disposable syringes and needles, with the Plastipak™ Syringe being a notable innovation. Additionally, BD provides medication management solutions, surgical products, and diagnostic instruments. The company has expanded its portfolio through strategic acquisitions, including CareFusion and C.R. Bard, enhancing its capabilities in medication management and surgical interventions. BD operates globally, addressing key healthcare challenges with a strong international presence.